| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/18/1998 | EP0823914A1 Systematic evolution of ligands by exponential enrichment: tissue selex |
| 02/18/1998 | CN1173898A Antifungal torpene compounds and process for produing the same |
| 02/18/1998 | CN1173897A Eukaryotic initiation factor SA (eif-5A) mutants |
| 02/18/1998 | CN1037437C 4 -benzoyl group isoxazol derivatives, its prodn. method, application and compsn. containing the same |
| 02/17/1998 | US5719287 Intermediates for inhibitors of HIV protease and method of preparation thereof |
| 02/17/1998 | US5719271 Hybrids; genetic engineering |
| 02/17/1998 | US5719131 Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules |
| 02/17/1998 | US5719127 Modified complement system regulators |
| 02/17/1998 | US5719125 Human chondromodulin-I protein |
| 02/17/1998 | US5719120 Use of endoglin polypeptides for modifying the regulatory activity of TGF-β |
| 02/17/1998 | US5719056 Purified nucleic acid having nucleotide sequence encoding an enzyme |
| 02/17/1998 | US5719055 Insertion of dna into host gene; genetic engineering |
| 02/17/1998 | US5719054 Recombinant virus vectors encoding human papillomavirus proteins |
| 02/17/1998 | US5719046 Genetic engineering; plants |
| 02/17/1998 | US5719044 Complexing |
| 02/17/1998 | US5719043 DNA sequences for an amino acid transporter, plasmids, bacteria, yeasts and plants containing a transporter and their use |
| 02/17/1998 | US5719041 DNA encoding ecotin homologs |
| 02/17/1998 | US5719030 Monoclonal antibody to prostate-derived acid phosphatase and method for determination of acid phosphatase using the same as well as kit for determination |
| 02/17/1998 | US5719028 Cleavase fragment length polymorphism |
| 02/17/1998 | US5719023 For identifying presence of known target sequence in double-stranded nucleic acid contained in a fixed cellular biological structure |
| 02/17/1998 | US5718915 Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme |
| 02/17/1998 | US5718902 Double recombinant vaccinia virus vaccines |
| 02/17/1998 | US5718901 Polypeptide |
| 02/17/1998 | US5718898 Monoclonal antibody or fragment thereof which specifically binds to gp200 of saccharomyces sensu stricto, but does not cross-react with any other species of yeast |
| 02/17/1998 | US5718883 Diabetic model for screening of therapeutic agents |
| 02/17/1998 | US5718079 Altered acetohydroxyacid synthase enzymes |
| 02/16/1998 | CA2213104A1 Novel purine nucleosidase |
| 02/13/1998 | CA2212786A1 Novel glutamine:fructose-6-phosphate amidotransferase, its production and use |
| 02/12/1998 | WO1998005967A1 Assessment of cervical cells |
| 02/12/1998 | WO1998005962A1 A method for quantitating competitive binding of molecules to proteins utilizing fluorescence polarization |
| 02/12/1998 | WO1998005798A1 Hiv coreceptor mutants |
| 02/12/1998 | WO1998005792A2 A novel human leptin receptor gene-related protein |
| 02/12/1998 | WO1998005791A1 Method to select and transfect cell subpopulations |
| 02/12/1998 | WO1998005790A1 Vector for activating the immune system against cells associated to papilloma viruses or sequences thereof |
| 02/12/1998 | WO1998005789A2 Controlled gene expression in plants |
| 02/12/1998 | WO1998005788A1 Improved process for the production of alcoholic beverages using maltseed |
| 02/12/1998 | WO1998005787A1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/12/1998 | WO1998005786A2 Afc1 and rce1:isoprenylated caax processing enzymes |
| 02/12/1998 | WO1998005785A1 Plant phytases and biotechnological applications |
| 02/12/1998 | WO1998005784A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 02/12/1998 | WO1998005783A1 A tumor necrosis factor related ligand |
| 02/12/1998 | WO1998005782A1 Testis-specific insulin homolog polypeptides |
| 02/12/1998 | WO1998005781A1 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005780A2 Voltage-gated calcium channel antagonist and methods |
| 02/12/1998 | WO1998005779A1 Modified tie-2-receptor ligands |
| 02/12/1998 | WO1998005778A1 Mammalian deep orange proteins |
| 02/12/1998 | WO1998005777A2 BCL-xη, A NOVEL BCL-x ISOFORM, AND USES RELATED THERETO |
| 02/12/1998 | WO1998005776A2 Secreted proteins and polynucleotides encoding them |
| 02/12/1998 | WO1998005775A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
| 02/12/1998 | WO1998005774A1 Use of a human vascular endothelial cell growth factor gene for direct genetic therapy |
| 02/12/1998 | WO1998005773A1 Methods of controlling beta dimer formation in hemoglobin |
| 02/12/1998 | WO1998005772A1 Ectoparasite histamine releasing factor, genes and uses thereof |
| 02/12/1998 | WO1998005771A1 Method for increasing the effect of antisense rna in cells |
| 02/12/1998 | WO1998005770A2 Antisense rna with a secondary structure |
| 02/12/1998 | WO1998005769A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
| 02/12/1998 | WO1998005768A1 Improved nucleic acids encoding a chimeric glycosyltransferase |
| 02/12/1998 | WO1998005767A1 Purification of plasmid dna by peg-precipitation and column chromatography |
| 02/12/1998 | WO1998005766A1 Target nucleic acid sequence amplification method |
| 02/12/1998 | WO1998005765A1 Double-stranded dna with cohesive end(s), and method of shuffling dna using the same |
| 02/12/1998 | WO1998005764A1 Nucleic acid pool and method for producing the same |
| 02/12/1998 | WO1998005763A1 Ku DEFICIENT CELLS AND NON-HUMAN TRANSGENIC ANIMALS |
| 02/12/1998 | WO1998005762A1 Plasminogen activator capable of being activated by thrombin |
| 02/12/1998 | WO1998005761A1 Age-1 polypeptides and related molecules and methods |
| 02/12/1998 | WO1998005760A2 Phosphate starvation-inducible proteins |
| 02/12/1998 | WO1998005759A1 Packaging cell lines for pseudotyped retroviral vectors |
| 02/12/1998 | WO1998005758A1 STRUCTURE AND EXPRESSION OF THE ALPHA-CARBOXYLTRANSFERASE SUBUNIT OF HETEROMERIC-ACETYL-CoA CARBOXYLASE |
| 02/12/1998 | WO1998005757A1 Method for reducing expression variability of transgenes in plant cells |
| 02/12/1998 | WO1998005754A2 Packaging cell lines containing expression constructs producing pseudotyped retroviral vectors |
| 02/12/1998 | WO1998005687A1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 02/12/1998 | WO1998005684A2 Mhc binding peptide oligomers and methods of use |
| 02/12/1998 | WO1998005678A2 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 02/12/1998 | WO1998005676A1 PEPTIDOGLYCAN BIOSYNTHETIC GENE murA FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/12/1998 | WO1998005673A1 Methods for purifying nucleic acids |
| 02/12/1998 | WO1998005672A1 Novel boronic acid-containing nucleic acids and their use as diagnostic agents |
| 02/12/1998 | WO1998005627A1 Boronic compound complexing reagents and highly stable complexes |
| 02/12/1998 | WO1998005356A1 NOVEL FtsL |
| 02/12/1998 | WO1998005352A1 Hypothalamus-specific polypeptides |
| 02/12/1998 | WO1998005344A1 Bacteriophage-mediated gene therapy |
| 02/12/1998 | WO1998005199A1 Shoot meristem specific promoter sequences |
| 02/12/1998 | WO1998005198A1 THE PROMOTER (FLt) FOR THE FULL-LENGTH TRANSCRIPT OF PEANUT CHLOROTIC STREAK CAULIMOVIRUS (PC1SV) |
| 02/12/1998 | WO1998000544A3 Growth arrest gene compositions and methods |
| 02/12/1998 | WO1997049989A3 Broad specificity affinity arrays: a qualitative approach to complex sample discrimination |
| 02/12/1998 | WO1997043414A3 A basal cell carcinoma tumor suppressor gene |
| 02/12/1998 | WO1997039130A3 Method for expressing and secreting keratinase |
| 02/12/1998 | WO1997019111A3 Monoclonal antibodies anti-cd6 and their uses |
| 02/12/1998 | DE19638362C1 Isolation of nucleic acids from sample |
| 02/12/1998 | DE19632121A1 Transgenic plant cells |
| 02/12/1998 | DE19631919A1 Anti-Sinn-RNA mit Sekundärstruktur Anti-sense RNA secondary structure |
| 02/12/1998 | DE19631918A1 Steigerung der Wirkung von Anti-Sinn-RNA in Zellen Increasing the effect of anti-sense RNA into cells |
| 02/12/1998 | DE19629095A1 Verwendung von rekombinantem Myelinprotein zur Behandlung von T-Zell vermittelten Autoimmunerkrankungen des peripheren Nervensystems Use of recombinant myelin protein for the treatment of T-cell mediated autoimmune disorders of the peripheral nervous system |
| 02/12/1998 | CA2595037A1 Modified tie-2 receptor ligands |
| 02/12/1998 | CA2263709A1 Ku deficient cells and non-human transgenic animals |
| 02/12/1998 | CA2262815A1 Method for reducing expression variability of transgenes in plant cells |
| 02/12/1998 | CA2262780A1 Shoot meristem specific promoter sequences |
| 02/12/1998 | CA2262753A1 Voltage-gated calcium channel antagonist and methods |
| 02/12/1998 | CA2262751A1 Plasminogen activator capable of being activated by thrombin |
| 02/12/1998 | CA2262696A1 Bcl-xy, a novel bcl-x isoform, and uses related thereto |
| 02/12/1998 | CA2262682A1 Boronic compound complexing reagents and highly stable complexes |
| 02/12/1998 | CA2262517A1 Afc1 and rce1:isoprenylated caax processing enzymes |
| 02/12/1998 | CA2262483A1 The promoter (flt) for the full-length transcript of peanut chlorotic streak caulimovirus (pc1sv) and expression of chimeric genes in plants |